These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7046026)

  • 41. [New effect biomarkers].
    De Palma G; Corradi M; Mutti A; Baccarelli A; Pesatori A; Bertazzi PA
    G Ital Med Lav Ergon; 2004; 26(4):302-10. PubMed ID: 15584437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrast-induced acute kidney injury (CIAKI).
    Solomon R
    Radiol Clin North Am; 2009 Sep; 47(5):783-8, v. PubMed ID: 19744593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The incidence and predictors of contrast-induced nephropathy in adequately hydrated elderly patients with impaired renal function.
    Park KW; Koo BK; Kim HL; Kim YS; Jo SH; Lee HY; Kang HJ; Cho YS; Chung WY; Yeon TJ; Chae IH; Choi DJ; Kim HS; Oh BH; Park YB
    Nephrol Dial Transplant; 2007 Jun; 22(6):1794-5. PubMed ID: 17324945
    [No Abstract]   [Full Text] [Related]  

  • 44. [Neurobehavioral tests in occupational medicine: diagnosis and prevention].
    Albini E; Benedetti L
    G Ital Med Lav Ergon; 2004; 26(3):251-4. PubMed ID: 15551956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Osmotic renal function in chronic kidney diseases].
    STRIBRNA J; SMAHELOVA R; SCHUECK O; FABIAN F
    Acta Univ Carol Med (Praha); 1961; Suppl 14():401-13. PubMed ID: 14039557
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical kidney function studies in sheep. III. Pathologic function changes in nephropathies of sheep and in urolithiasis of rams and billy goats].
    Bickhardt K; Ganter M; Steinmann Chavez C
    Dtsch Tierarztl Wochenschr; 1995 Jan; 102(1):59-64. PubMed ID: 7781544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toxic nephropathies: core curriculum 2010.
    Perazella MA
    Am J Kidney Dis; 2010 Feb; 55(2):399-409. PubMed ID: 20042257
    [No Abstract]   [Full Text] [Related]  

  • 48. [IMPORTANCE OF "CLEARANCES" FOR DIAGNOSIS AND PROGNOSIS OF NEPHROPATHIES].
    BARBONI A; MELLI A; GOLINELLI G
    Arcisp S Anna Ferrara; 1965; 18():141-55. PubMed ID: 14325316
    [No Abstract]   [Full Text] [Related]  

  • 49. [Laboratory facilities in the dignity and prognosis of nephropathies].
    SANCHEZ RUIZ M
    Actual Medica; 1947 Nov; 33(275):597-609. PubMed ID: 18898008
    [No Abstract]   [Full Text] [Related]  

  • 50. [Latent chronic nephropathies with acute exacerbation and fatal outcome in soldiers].
    RAJKOVIC A; ZENGOVIC J
    Vojnosanit Pregl; 1961 Jan; 18():69-71. PubMed ID: 13739229
    [No Abstract]   [Full Text] [Related]  

  • 51. [Practical indications for the treatment of chronic nephropathies].
    RAPIN M
    Bull Med; 1954 Jun; 68(11-12):289-93. PubMed ID: 13190332
    [No Abstract]   [Full Text] [Related]  

  • 52. [What do we know about occupational diseases of the kidney and urinary tract?].
    Wolf H
    Ugeskr Laeger; 1983 Dec; 145(50):3914-6. PubMed ID: 6665918
    [No Abstract]   [Full Text] [Related]  

  • 53. [Chronic occupational nephropathies].
    Danan M; Lagrue G
    Rev Prat; 1982 Mar; 32(17):1121-35. PubMed ID: 7046026
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the problem of chemico-toxic occupational nephropathies].
    Kaganov AL; Epshteĭn EI
    Gig Tr Prof Zabol; 1969 Jan; 13(1):31-5. PubMed ID: 5809325
    [No Abstract]   [Full Text] [Related]  

  • 55. [Occupational nephropathies].
    Melino C
    Clin Ter; 1986 Jan; 116(1):57-60. PubMed ID: 3698524
    [No Abstract]   [Full Text] [Related]  

  • 56. [Secondary nephropathies in occupational health practice. I. Secondary nephropathies due to occupational exposure].
    Antonowicz-Juchniewicz J; Jodkowska A; Kwiecińiska D
    Med Pr; 2006; 57(4):389-400. PubMed ID: 17133921
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.